Related Experiment Videos

Influence of microalbuminuria in achieving blood pressure goals

Irena Duka1, George Bakris

  • 1Department of Medicine, Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.

Current Opinion in Nephrology and Hypertension
|August 13, 2008
PubMed

Insights

Microalbuminuria is a key risk marker for cardiovascular events in hypertension. Effective management involves blood pressure control and specific antihypertensive drugs like ACE inhibitors and ARBs, alongside lifestyle factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Management

Background:

  • Microalbuminuria is an independent risk marker for cardiovascular events in hypertensive individuals, irrespective of diabetes status.
  • While blood pressure reduction is crucial, factors like salt intake also influence microalbuminuria by affecting oxidant stress.

Purpose of the Study:

  • To review current evidence on the relationship between blood pressure and microalbuminuria.
  • To discuss the rationale behind blood pressure goals in proteinuric patients.
  • To evaluate the role of different antihypertensive agents in managing microalbuminuria.

Main Methods:

  • Review of clinical trials and existing evidence on antihypertensive therapies.
  • Analysis of drug classes affecting the renin-angiotensin system.
  • Consideration of medications with antiproteinuric and antioxidant properties.

Main Results:

  • Angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) are recommended as first-line therapy due to their blood pressure-independent antiproteinuric effect.
  • Combination therapy with ACE inhibitors and ARBs, or other agents like calcium antagonists or aldosterone blockers, can further reduce albuminuria.
  • Beta-blockers with alpha-blocking properties, such as carvedilol, may reduce microalbuminuria due to antioxidant effects.

Conclusions:

  • Current evidence supports specific antihypertensive strategies for patients with microalbuminuria.
  • The choice of medication should consider blood pressure-independent effects and potential benefits like antioxidant properties.
  • Further research may refine treatment guidelines for managing microalbuminuria in hypertensive patients.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...